Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40762485	s-gbmab	— (—)	3261	4038	100.00%	Distribution not available
40762485	s-gbmab	u/ml (u/ml)	35	132	24.24%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Nephropathy related operations

348

329

11.32

323.01

1.8

1.1

45.17

—

u/ml

—

Non-invasive ventilation

417

393

10.31

307.65

1.4

1.2

—

u/ml

—

Dialysis, with operation codes

363

244

15.94

307.65

1.8

1.1

45.17

—

u/ml

—

Renal failure

1213

873

13.43

307.65

1.3

1.2

45.17

—

u/ml

—

Acute renal failure

606

388

16.72

307.65

1.4

1.1

50.80

—

u/ml

—

Chronic kidney disease

906

590

16.33

307.65

1.4

1.1

45.17

—

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

281

108

20.13

294.36

1.3

1.1

—

u/ml

—

Other necrotizing vasculopathies

230

171

14.63

249.19

3.7

1.1

42.60

—

u/ml

—

Secondary hypertension

184

105

18.26

225.60

1.3

1.0

—

u/ml

—

ILD, hospital admissions 3, with pneumonia sepsis

209

172

12.95

212.38

1.4

1.1

—

u/ml

—

Other necrotizing vasculopathies (FG)

192

139

14.97

211.13

2.9

1.1

—

u/ml

—

Nephrotic syndrome

116

17.55

137.91

1.2

1.1

—

u/ml

—

Acute tubulo-interstitial nephritis

478

1216

3.52

133.80

1.2

—

u/ml

—

Other disorders involving the immune mechanism, not elsewhere classified

117

16.19

133.21

1.2

1.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

114

16.92

132.60

1.2

1.1

—

Wegener granulomatosis

27.67

121.13

4.8

1.1

—

u/ml

—

Diabetic nephropathy, excluding more controls

237

361

5.67

115.81

1.1

1.2

—

u/ml

—

Second line medication for Crohn's disease

515

1726

3.02

115.41

1.8

1.2

—

30.21

u/ml

—

L04AX Other immunosuppressants

502

1684

3.02

112.34

1.8

1.2

—

30.21

u/ml

—

Chronic nephritic syndrome

108

100

11.56

101.84

1.2

1.1

—

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

219

277

5.60

99.67

1.1

1.3

—

u/ml

—

IgA nephropathy (IgA glomerulonephritis)

14.92

96.83

1.1

—

Microscopic polyangiitis

56.27

90.31

2.1

1.1

—

u/ml

—

Anaemia in chronic diseases classified elsewhere

14.79

88.98

1.6

1.1

—

Non-ischemic cardiomyopathy

299

668

3.73

88.89

1.2

1.1

—

u/ml

—

Oedema, not elsewhere classified

270

751

3.62

81.44

1.1

—

u/ml

—

ILD-related respiratory insufficiency

11.44

77.56

1.6

1.2

—

u/ml

—

Disorders resulting from impaired renal tubular function

9.67

72.39

1.6

1.2

—

u/ml

—

Hypertensive heart and/or renal disease

220

433

3.99

70.71

1.2

—

u/ml

—

Gout, strict definition

206

541

3.89

68.59

1.2

1.1

—

u/ml

—

Isolated proteinuria

10.82

65.90

1.2

1.1

—

u/ml

—

Implicit fungal Sepsis

11.37

65.72

1.9

1.2

—

u/ml

—

Abnormal findings on examination of urine, without diagnosis

113

8.07

63.33

1.5

1.2

—

u/ml

—

Hyperkalaemia

103

8.35

62.60

1.1

1.2

—

u/ml

—

Hypertensive Renal Disease

11.50

61.84

1.1

—

u/ml

—

Fungal Sepsis

9.70

60.57

1.9

1.2

—

u/ml

—

Pneumonia due to other infectious organisms, not elsewhere classified

11.03

59.90

2.0

1.1

—

u/ml

—

Idiopathic pulmonary fibrosis

104

183

5.86

56.68

1.2

1.1

—

u/ml

—

Pleural effusion

161

409

4.01

56.20

1.2

1.1

—

u/ml

—

Explicit bacterial Sepsis

107

198

5.51

55.07

1.2

—

u/ml

—

Respiratory disorders in diseases classified elsewhere

15.60

53.50

4.2

1.0

—

u/ml

—

Other disorders of skin and subcutaneous tissue

487

2091

2.15

53.07

1.2

1.3

—

38.80

u/ml

—

Type 1 diabetes

210

662

3.20

52.56

1.1

1.3

—

u/ml

—

Pneumocystosis

11.68

49.60

2.0

1.1

—

u/ml

—

Streptococcal septicaemia

178

5.46

48.35

1.2

—

u/ml

—

Other soft tissue disorders, not elsewhere classified

607

1928

1.95

47.35

1.2

1.3

—

49.07

u/ml

—

Other nutritional deficiencies

423

1947

2.14

46.13

1.1

1.3

—

31.25

u/ml

—

Obesity due to excess calories

316

1328

2.40

45.61

1.1

1.2

—

34.10

u/ml

—

Type 1 diabetes, wide definition, subgroup 1

175

543

3.26

45.09

1.1

1.3

—

u/ml

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

105

230

4.69

44.69

1.1

—

Enlarged lymph nodes

130

338

3.90

43.94

1.1

—

u/ml

—

Other specified/unspecified necrotizing vasculopathies

14.93

43.83

2.6

1.1

—

Codeine

609

1757

1.91

43.50

1.2

1.3

—

54.42

u/ml

—

Obesity

401

1879

2.13

43.38

1.1

1.3

—

34.10

u/ml

—

Obesity and other hyperalimentation

401

1884

2.12

43.00

1.1

1.3

—

34.10

u/ml

—

Protozoal diseases

8.17

42.50

1.9

1.1

—

u/ml

—

Isolated proteinuria with specified morphological lesion

16.23

42.19

1.0

1.1

—

u/ml

—

Type 1 diabetes, wide definition

179

587

3.08

42.05

1.1

1.3

—

u/ml

—

Undetermined asthma, excluding more controls

183

4.97

41.62

1.2

1.1

—

u/ml

—

Other diseases of pericardium

7.20

39.99

1.2

1.0

—

u/ml

—

Polyarteritis nodosa and related conditions

11.64

37.75

1.5

1.1

—

Other acute lower respiratory infections

362

1658

2.10

37.58

1.4

1.3

—

75.40

u/ml

—

Codeine or tramadol medication

721

2322

1.73

37.26

1.2

1.3

—

50.07

u/ml

—

Pain in limb

487

1864

1.90

36.32

1.1

1.3

—

49.07

u/ml

—

Opioids

608

1777

1.80

35.96

1.1

1.4

—

49.07

u/ml

—

Vasculitis limited to skin, not elsewhere classified

7.60

35.92

1.5

1.1

—

u/ml

—

Disorders of mineral metabolism

168

4.86

35.81

1.2

1.1

—

Other and unspecified vasculitis limited to skin

7.88

35.56

1.5

1.1

—

u/ml

—

Polymyalgia rheumatica

114

316

3.67

35.29

1.3

1.1

—

Biguanides

587

2030

1.79

35.16

1.1

1.3

—

58.40

u/ml

—

Respiratory insufficiency

129

5.35

34.07

1.1

—

u/ml

—

Disorders of calcium metabolism

126

5.44

34.06

1.3

1.1

—

Hypertensive Heart Disease

149

399

3.08

33.53

1.3

1.2

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

15.57

33.48

1.2

1.1

—

Later onset COPD, excluding more controls

143

357

3.16

32.99

1.1

—

u/ml

—

Idiopathic gout

243

3.95

32.28

1.1

—

u/ml

—

Nerve, nerve root and plexus disorders

653

2440

1.69

32.10

1.3

1.2

—

50.07

u/ml

—

Hypersensitivity angiitis

57.80

32.05

8.6

1.1

42.60

—

u/ml

—

Acute nephritic syndrome

8.26

30.49

1.6

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

128

421

3.08

30.19

1.3

1.1

—

u/ml

—

Hyperlipidaemia, other/unspecified

253

1091

2.21

30.13

1.2

—

u/ml

—

Hydronephrosis

197

4.11

29.29

1.1

—

u/ml

—

Allergic purpura

6.54

29.23

1.2

—

Hypothyroidism, drug reimbursement

132

4.42

29.21

1.1

1.3

—

Eosinophilic disease (BM)

16.30

28.99

1.2

—

Hypokalaemia

238

3.70

27.53

1.1

—

u/ml

—

Other specific joint derangements/joint disorders

410

1513

1.82

26.83

1.2

1.3

—

50.10

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

129

4.79

26.29

1.1

—

Giant cell arteritis

5.73

26.27

1.2

1.1

—

Other CVD (FINNGEN)

127

4.38

25.88

1.1

1.2

—

u/ml

—

Syncope and collapse

258

1110

2.07

25.83

1.1

1.2

—

u/ml

—

Episodal and paroxysmal disorders

655

2092

1.61

25.81

1.2

1.3

—

39.42

u/ml

—

Hypo-osmolality and hyponatraemia

114

388

2.96

25.22

1.2

1.1

—

u/ml

—

Osteomyelitis

177

4.04

24.89

1.1

1.2

—

Insulin, fast-acting (human)

104

341

3.08

24.72

1.1

1.3

—

u/ml

—

Symptoms and signs concerning food and fluid intake

196

3.82

24.52

1.3

1.1

—

Other disorders of white blood cells

145

4.38

24.45

1.2

—

Peripheral arterial reconstruction

134

508

2.67

24.41

1.2

—

u/ml

—

Non-allergic asthma (mode), excluding more controls

314

3.14

24.41

1.3

1.1

—

u/ml

—

Other pleural conditions

237

3.51

23.98

1.2

1.1

—

u/ml

—

Soft tissue disorders

603

1957

1.61

23.66

1.1

1.3

—

53.44

u/ml

—

Multiple myeloma and malignant plasma cell neoplasms

116

4.60

21.81

1.2

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

118

4.52

21.36

1.2

—

Thrombotic microangiopathy

15.94

21.32

5.7

1.1

—

Hernia of abdominal wall, postoperative

101

355

2.87

21.27

1.6

1.1

—

u/ml

—

Multiple myeloma and malignant plasma cell neoplasms

119

4.48

21.14

1.2

—

Neurological diseases

492

1516

1.64

20.89

1.2

1.3

—

39.42

u/ml

—

Viral hepatitis, IBD co-morbidity

6.88

20.80

1.2

1.1

—

Infections of the skin and subcutaneous tissue

332

1894

1.75

20.57

1.2

1.3

—

75.40

u/ml

—

Mixed connective tissue disease

152

3.95

20.48

1.2

1.1

—

Myocarditis

6.43

20.10

1.2

1.0

—

Cardiomyopathy

114

441

2.61

20.01

1.4

1.1

—

u/ml

—

Vocal cord dysfunction

184

3.51

19.99

1.3

1.1

—

u/ml

—

Other specified/unspecified systemic involvement of connective tissue

120

4.32

19.97

1.2

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

211

3.41

19.96

1.1

—

Pain, not elsewhere classified

142

614

2.33

19.57

1.1

1.2

—

Pain in joint

345

1319

1.74

19.37

1.2

1.3

—

62.70

—

Other joint disorders

472

1574

1.60

18.63

1.1

1.3

—

55.75

u/ml

—

Acute sinusitis

281

1469

1.79

18.61

1.4

1.2

—

34.10

u/ml

—

Adrenocortical insufficiency

5.00

18.59

1.2

1.1

—

Adult respiratory distress syndrome

8.21

18.46

1.4

1.1

—

u/ml

—

Drug-induced osteoporosis with pathological fracture

8.17

18.44

1.1

1.0

—

Recurrent and persistent haematuria

11.21

18.41

1.1

—

Chronic ulcer of skin, not elsewhere classified

184

3.48

18.26

1.1

—

Intracranial trauma

299

1269

1.77

18.24

1.1

1.3

—

39.42

u/ml

—

Cytomegaloviral disease

5.89

18.17

1.5

1.1

—

Other/unspecified cytomegaloviral diseases

6.50

18.15

1.5

1.1

—

COPD-related respiratory insufficiency

331

2.78

18.12

1.1

—

Cytomegalovirus infection, IBD co-morbidity

5.80

17.87

1.5

1.1

—

Abnormal findings on diagnostic imaging of other body structures

296

2.87

17.73

1.1

1.2

—

Other disorders of adrenal gland

107

4.29

17.45

1.2

1.1

—

Familial hypercholesterolemia

100

390

2.59

17.34

1.1

—

u/ml

—

Other and unspecified drugs and medicaments

196

3.31

17.22

1.1

—

Short Achilles tendon (acquired)

5.78

16.87

1.3

—

Amputation of toe

194

3.30

16.84

1.2

1.1

—

Disorders of synovium and tendon

287

1507

1.72

16.58

1.2

1.4

—

31.25

u/ml

—

Pulmonary eosinophilia, not elsewhere classified

9.49

16.55

1.2

1.0

—

Acquired haemolytic anaemia

5.51

16.47

1.1

—

Pericarditis

4.90

16.42

1.5

1.0

—

u/ml

—

Polyarteritis nodosa

12.09

16.37

1.5

1.1

—

Gout due to impairment of renal function

7.89

16.30

1.1

—

Exposure to unspecified factor

526

2749

1.49

16.17

1.2

1.3

—

50.17

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

540

2350

1.48

15.89

1.1

1.3

—

32.42

u/ml

—

Drug-induced adrenocortical insufficiency

6.82

15.86

1.2

1.1

—

Secondary right heart disease

104

4.13

15.48

1.2

1.1

—

u/ml

—

Scleritis and episcleritis

131

3.72

15.43

1.5

1.1

—

Other abnormalities of plasma proteins

7.62

15.36

1.1

—

u/ml

—

Emphysema

171

3.32

15.18

1.1

—

u/ml

—

Substance abuse, excluding more controls

317

1709

1.63

14.85

1.1

1.3

—

46.92

u/ml

—

Low back pain

390

1935

1.56

14.81

1.1

1.3

—

47.58

u/ml

—

Temporal arteritis

4.49

14.79

1.2

1.0

—

Cardiac arrest

4.19

14.58

1.1

1.0

—

Cardiomyopathies, Primary/intrinsic

289

2.69

14.50

1.1

—

u/ml

—

Problems related to lifestyle

250

2.83

14.49

1.1

—

u/ml

—

Concussion

246

1235

1.73

14.45

1.1

1.3

—

39.42

u/ml

—

Other complications of surgical and medical care, not elsewhere classified

246

2.84

14.35

1.1

1.3

—

Weight loss

252

2.81

14.31

1.4

1.1

—

Other pulmonary heart/vessel disease

120

3.74

14.21

1.2

1.1

—

u/ml

—

Cardiomyopathy (excluding other)

299

2.63

14.10

1.1

—

u/ml

—

Amyloidosis

6.39

13.81

1.0

1.4

—

Kela reimbursement Agammaglobulinemia (D80-84)

8.64

13.77

1.3

1.1

—

Giant cell arteritis with polymyalgia rheumatica

4.23

13.74

1.2

1.0

—

Disorders of skin appendages

243

1435

1.70

13.71

1.2

1.3

—

38.79

—

Suppurative and necrotic conditions of lower respiratory tract

143

3.41

13.59

1.3

1.2

—

u/ml

—

Charcot foot

6.48

13.36

1.0

1.3

—

Acidosis

5.88

13.28

1.1

1.3

—

Other infectious diseases

213

2.90

13.23

1.3

1.1

—

Non-follicular lymphoma

265

2.67

13.04

1.3

1.1

—

u/ml

—

Shoulder lesions

413

1689

1.50

12.84

1.3

—

65.20

u/ml

—

Arthropathies in other diseases classified elsewhere

4.17

12.80

1.0

1.1

—

Eosinophilia

5.29

12.80

1.2

1.1

—

Haemolytic anaemias

3.96

12.59

1.1

—

Non-follicular lymphoma, hilmo, excluding all cancers

272

2.60

12.40

1.3

1.1

—

u/ml

—

Respiratory conditions due to other external agents

5.49

12.37

1.8

1.1

—

Acute drug-induced interstitial lung disorder

10.54

12.34

2.4

1.1

—

Injuries to the head

576

2695

1.40

12.32

1.2

1.3

—

50.17

u/ml

—

Dorsalgia

525

2001

1.42

12.19

1.2

1.3

—

47.58

u/ml

—

Episcleritis

109

3.63

12.17

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

310

2.48

12.16

1.1

—

Pulmonary oedema

5.38

11.60

1.2

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

196

2.84

11.54

1.2

1.1

—

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

326

2036

1.52

11.44

1.1

1.3

—

61.60

u/ml

—

Infection due to other mycobacteria

6.06

11.40

1.1

1.0

—

Acute peritonitis

171

2.96

11.31

1.3

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

261

2.56

11.31

1.1

—

u/ml

—

Amyloidosis, other/unspecified

6.30

11.26

1.0

1.4

—

Substance abuse

317

2003

1.52

11.22

1.1

1.3

—

61.60

u/ml

—

Pneumonia due to Streptococcus pneumoniae

3.91

11.12

1.4

1.1

—

Other and unspecified disorders of white blood cells

107

3.52

11.03

1.2

—

Neoplasms

395

1440

1.47

11.01

1.2

1.3

—

58.42

u/ml

—

Abnormal weight loss

236

2.61

10.95

1.1

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

23.77

10.94

1.3

1.0

—

Small fibre neuropathy

4.28

10.87

1.2

1.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

4.39

10.83

1.2

1.1

—

Multiple myeloma

4.39

10.83

1.2

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

500

2522

1.39

10.80

1.1

1.3

—

30.21

u/ml

—

Other/unspecified rheumatoid arthritis

341

2.31

10.75

1.1

—

Decubitus ulcer and pressure area

139

3.14

10.73

1.2

1.1

—

Henoch-Schönlein purpura nephritis (HSPN)

11.92

10.30

1.4

1.8

—

Acquired absence of limb

8.08

10.22

1.1

—

Rapidly progressive nephritic syndrome

25.43

9.71

1.3

1.2

—

Sicca syndrome [Sjögren]

192

2.68

9.70

1.1

—

u/ml

—

Amputation of foot

4.01

9.65

1.2

—

Pyothorax

118

3.19

9.50

1.3

1.2

—

u/ml

—

Thrombocytopenia, unspecified

184

2.69

9.39

1.2

1.1

—

u/ml

—

Benign neoplasms

394

1570

1.42

9.35

1.2

1.3

—

53.30

u/ml

—

Pure hyperglyceridaemia

4.97

9.35

1.1

—

Spondylopathies (FG)

311

2.26

9.33

1.2

1.1

—

Carpal tunnel syndrome

291

1777

1.48

9.25

1.2

—

38.80

u/ml

—

Benign neoplasms

512

2111

1.36

9.15

1.2

1.3

—

53.30

u/ml

—

Infective dermatitis

304

2.25

8.96

1.1

—

Thyroiditis, ILD-related definition

236

2.43

8.93

1.1

—

Erythema nodosum

3.97

8.90

1.0

—

Polyarthritis, unspecified

3.64

8.85

1.2

1.1

—

Crohn's disease NAS

151

2.81

8.75

1.2

1.1

—

Pruritus

251

2.37

8.73

1.1

—

Pyogenic arthritis

164

2.71

8.57

1.0

1.1

—

Intracranial injury

287

1906

1.46

8.53

1.1

1.3

—

75.40

u/ml

—

Explicit fungal Sepsis

7.88

8.49

1.3

1.1

—

Fibromyalgia

172

2.64

8.35

1.2

1.3

—

u/ml

—

Atypical mycobacterium lung infection

5.51

8.27

1.0

1.1

—

Diseases of peritoneum

277

2.26

8.23

1.2

1.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

234

2.36

8.15

1.8

1.2

—

Unspecified contracted kidney

9.51

8.15

1.1

—

Disorders of magnesium metabolism

9.46

8.14

1.3

1.2

—

Etanercept

141

2.79

8.07

1.1

—

Asthma mixed form (mode), excluding more controls

3.65

8.00

1.1

—

Cirrhosis of liver, NAS

137

2.81

7.93

1.1

1.2

—

3.85

7.84

1.1

1.2

—

Other obstructive and reflux uropathy

3.50

7.83

1.1

1.2

—

Dizziness and giddiness

372

2201

1.37

7.79

1.1

1.3

—

38.80

u/ml

—

Cholangitis (primary sclerosing, PSC)

144

2.74

7.77

1.2

1.1

—

8.84

7.66

1.4

1.1

—

Folate deficiency anaemia

6.91

7.66

1.0

1.1

—

Chorioretinal inflammation

3.64

7.61

1.2

1.1

—

Other metabolic disorders

261

2.23

7.58

1.7

1.2

—

Other specified/unspecified inflammatory spondylopathies

103

3.04

7.47

1.3

1.1

—

Other diseases of stomach and duodenum

159

2.61

7.44

1.3

1.1

—

u/ml

—

Nonalcoholic steatohepatitis

6.57

7.30

1.0

1.1

—

Congenital iodine-deficiency syndrome/hypothyroidism

3.53

7.29

1.0

—

Infective bursitis

3.35

7.27

1.2

—

Asthma mixed form (mode)

3.40

7.24

1.1

—

ILD and respiratory illness in diseases classified elsewhere

8.11

7.19

1.4

1.1

—

Extreme obesity with alveolar hypoventilation

3.15

7.15

1.0

1.2

—

u/ml

—

Other specified disorders of kidney and ureter

3.23

7.14

1.1

1.2

—

Constipation

434

2346

1.33

7.14

1.1

1.3

—

35.17

u/ml

—

Juvenile arthritis (FINNGEN)

3.28

7.11

1.1

1.3

—

Cardiomyopathy, other and unspecified

169

2.50

7.08

1.9

1.0

—

Systemic sclerosis (FG)

4.25

7.03

2.1

1.0

—

Recurring oral aphthae

118

2.83

7.02

1.7

1.2

—

Causalgia

4.66

6.96

1.1

—

Osteonecrosis

147

2.61

6.96

1.1

—

Malignant immunoproliferative diseases

6.20

6.95

1.1

—

Amputation of ankle bones

3.76

6.95

1.2

1.1

—

Hypersensitivity pneumonitis due to organic dust

4.06

6.94

1.2

1.1

—

Viral pneumonia (known virus, not influenza)

3.62

6.90

1.3

1.1

—

Drug-induced cataract

3.62

6.90

1.5

1.1

—

Tuberculosis

166

2.49

6.84

1.3

1.1

—

u/ml

—

Other diseases of upper respiratory tract

571

2331

1.28

6.80

1.4

1.2

—

40.07

u/ml

—

Sequelae of other external causes

133

2.66

6.65

1.3

1.1

—

Pneumonia derived septicemia

3.08

6.64

1.4

1.2

—

Ocular pain

181

2.39

6.61

1.1

—

Other meningitis

4.64

6.48

1.3

1.1

—

Dermatitis due to substances taken internally

135

2.62

6.47

2.1

1.2

—

Cholelithiasis, broad definition with cholecystitis

416

2170

1.32

6.46

1.1

1.3

—

38.80

u/ml

—

Congenital malformations of the urinary system

147

2.54

6.44

1.2

—

Other conditions related to polyarteritis nodosa

19.81

6.41

1.8

1.2

—

Infection of intervertebral disc (pyogenic)

4.33

6.34

1.5

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

114

2.74

6.27

1.3

1.1

—

Arterial embolism and thrombosis

149

2.51

6.27

1.2

1.1

—

Biological medicines for asthma

5.11

6.26

1.4

1.1

—

Retinal vascular disorders

338

1.97

6.24

1.1

—

u/ml

—

Other aneurysm

144

2.53

6.20

1.2

1.1

—

Left bundle-branch block

144

2.52

6.19

1.2

1.0

—

Other disorders of iris and ciliary body

3.34

6.16

1.0

1.1

—

Retinal vascular occlusion

333

1.97

6.14

1.1

—

u/ml

—

Disorder of lipoprotein metabolism, unspecified

326

1.97

6.14

1.5

1.1

—

Failure and rejection of transplanted organs and tissues

4.40

6.07

1.3

1.1

—

Tobacco use

128

2.60

6.05

1.1

—

Mixed hyperlipidaemia

3.01

5.97

1.0

1.2

—

Systemic sclerosis

3.73

5.94

2.1

1.0

—

Later onset COPD

149

758

1.55

5.91

1.1

1.2

—

u/ml

—

Other disorders of gingiva or/and edentulous alveolar ridge

101

2.80

5.90

1.5

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

437

2239

1.29

5.88

1.2

1.3

—

31.25

u/ml

—

Dependence on enabling machines and devices, not elsewhere classified

5.60

5.80

1.5

1.1

—

Ulcer of oesophagus

180

2.30

5.78

1.2

1.1

—

Systemic sclerosis, icd10

3.66

5.78

2.1

1.1

—

Drug-induced osteoporosis

5.12

5.78

1.1

1.0

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.28

5.75

1.3

1.2

—

u/ml

—

Crohn's disease of large intestine

120

2.61

5.72

1.2

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

6.09

5.67

1.1

—

Pneumococcal septicemia

2.91

5.64

1.4

1.1

—

Late syphilis

3.91

5.58

1.0

1.1

—

Duodenal ulcer

296

1.97

5.58

1.2

1.1

—

u/ml

—

Hypothyroidism, other/unspecified

423

2175

1.29

5.57

1.1

1.3

—

31.25

u/ml

—

Generalized skin eruption due to drugs and medicaments

2.76

5.54

2.3

1.2

—

Presbycusis

372

1.86

5.54

1.2

1.1

—

u/ml

—

Scleritis

4.59

5.54

2.6

1.1

—

Dermatopolymyositis (FG)

4.89

5.52

1.0

1.1

—

Cholelithiasis

391

2121

1.29

5.50

1.1

1.3

—

38.80

u/ml

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

204

2.17

5.47

1.2

1.1

—

Rosacea

285

1.98

5.44

1.4

1.3

—

Acute generalized exanthematous pustulosis

112

2.62

5.40

2.2

1.1

—

Tularaemia

4.22

5.39

1.1

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

12.04

5.39

1.1

1.0

—

Collagenous colitis

232

2.08

5.37

1.1

—

Abnormalities of gait and mobility

336

1.89

5.34

1.1

—

u/ml

—

Secondary thrombocytopenia

4.44

5.33

1.1

—

Chronic hepatitis, not elsewhere classified

2.95

5.32

1.1

—

Other renal tubulo-interstitial diseases

3.89

5.27

1.1

—

Disorders of tooth development and eruption

2.67

5.24

1.3

1.2

—

Pneumothorax

163

2.29

5.21

1.1

—

Special screening examination for other diseases and disorders

195

2.17

5.21

1.2

—

Disorders of the thyroid gland

454

2353

1.26

5.20

1.1

1.3

—

31.25

u/ml

—

Occupational exposure to risk-factors

2.72

5.19

1.4

1.2

—

u/ml

—

Nummular dermatitis

222

2.09

5.18

1.4

1.1

—

u/ml

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

389

1.81

5.18

1.3

1.2

—

u/ml

—

Total colectomy operation

103

2.65

5.16

1.1

—

Total colectomy

103

2.65

5.16

1.1

—

Other juvenile arthritis

2.96

5.15

1.1

1.4

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

121

2.49

5.12

1.1

1.4

—

Algoneurodystrophy

3.03

5.11

1.0

1.2

—

Monoarthritis, not elsewhere classified

2.74

5.11

1.2

1.1

—

Other overlap syndromes

4.26

5.11

1.2

1.1

—

Childhood asthma (age<16), excluding more controls

138

2.25

5.08

1.1

—

571

1.63

5.02

1.1

—

u/ml

—

Parodontitis, under 40 years and operation codes

185

2.17

5.02

1.6

1.4

—

Pneumonitis due to solids and liquids

205

2.11

5.01

1.0

1.1

—

Chronic iridocyclitis

111

2.54

4.97

1.2

—

Convalescence

117

2.50

4.96

1.2

—

Parodontitis, operation under 40 years and operation codes

186

2.16

4.96

1.6

1.3

—

Malignant immunoproliferative diseases

4.41

4.87

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

200

1427

1.39

4.86

1.3

—

51.20

u/ml

—

Disorders of optic nerve and visual pathways

228

2.03

4.85

1.2

1.3

—

Use of anticholinesterases

862

0.56

4.81

1.1

—

N06DA Anticholinesterases

862

0.56

4.81

1.1

—

Blindness, monocular

5.13

4.81

1.1

—

Paralytic strabismus

189

2.13

4.79

1.0

1.1

—

Fracture of lower leg, including ankle

248

1844

1.34

4.79

1.1

1.3

—

35.17

u/ml

—

Injuries to the ankle and foot

299

2087

1.31

4.75

1.2

1.3

—

53.44

u/ml

—

Diffuse large B-cell lymphoma, helper endpoint

114

2.48

4.72

1.1

1.2

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

114

2.48

4.72

1.1

1.2

—

Other and unspecified vascular occlusions

265

1.94

4.72

1.1

—

u/ml

—

Visual field defects

224

2.02

4.70

1.2

1.1

—

Other nonautoimmune haemolytic anaemias

15.66

4.70

1.0

1.2

—

Parodontitis, under 40 years

197

2.09

4.70

1.6

1.3

—

Parodontitis, under 40 years, or operation codes

197

2.09

4.70

1.6

1.3

—

Injuries to the elbow and forearm

304

2115

1.30

4.67

1.3

—

42.14

u/ml

—

Hidradenitis suppurativa

2.87

4.66

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

380

2044

1.27

4.65

1.1

1.3

—

31.25

u/ml

—

Abscess of lung

3.56

4.64

1.1

—

Discitis, unspecified

3.40

4.63

1.0

1.1

—

Juvenile rheumatoid arthirtis

3.53

4.62

1.1

1.2

—

Abdominal aortic aneurysm (AAA)

293

1.87

4.61

1.2

1.1

—

Other and unspecified rosacea

206

2.05

4.58

1.5

1.3

—

Psoriatic and enteropathic arthropathies

261

1.92

4.57

1.1

—

Lymphoid leukaemia

160

2.21

4.57

1.1

1.2

—

Diffuse large B-cell lymphoma

116

2.44

4.56

1.1

1.2

—

Other and unspecified acquired haemolytic anaemias

4.88

4.56

1.3

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

2.90

4.51

1.1

1.2

—

Chronic lymphocytic leukaemia, helper endpoint

2.90

4.51

1.1

1.2

—

Postmenopausal osteoporosis with pathological fracture

123

2.38

4.49

1.1

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.11

4.47

1.0

1.1

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

4.11

4.47

1.0

1.5

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

416

1967

1.25

4.43

1.1

1.3

—

38.80

u/ml

—

Arterial embolism and thrombosis of lower extremity artery

2.71

4.42

1.1

1.2

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

2.64

4.41

1.3

1.1

—

u/ml

—

Malignant neoplasm of endocrine gland

169

2.15

4.40

1.2

1.1

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

4.32

4.38

2.7

1.5

—

Third [oculomotor] nerve palsy

3.39

4.35

1.1

—

Vascular disorders of the intestines

170

2.13

4.34

1.2

1.1

—

u/ml

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

415

1967

1.25

4.34

1.1

1.3

—

38.80

u/ml

—

Vitamin B12 deficiency anaemia

295

1.84

4.32

1.1

—

Malignant neoplasm, wide definition for exclusion

415

1969

1.25

4.31

1.1

1.3

—

38.80

u/ml

—

Lymphoid leukaemia

165

2.14

4.26

1.1

1.2

—

Other epidermal thickening

114

2.39

4.24

1.4

1.2

—

u/ml

—

Disorders of oesophagus in diseases classified elsewhere

3.19

4.23

1.6

1.1

—

Melanocytic naevi of lower limb, including hip

2.52

4.22

1.1

1.2

—

Melanocytic naevi of lower limb, including hip

2.52

4.22

1.1

1.2

—

Behavioural disorders, excluding more controls

3.64

4.20

1.0

1.3

—

Benign neoplasm: Ascending colon

379

1.72

4.20

1.2

1.1

—

Gingival hyperplasia

2.77

4.19

1.7

1.2

—

Visual impairment including blindness (binocular or monocular)

173

2.10

4.17

1.1

—

Other secondary coxarthrosis

2.69

4.17

1.2

1.1

—

Mental and behavioural disorders due to opioids

2.55

4.14

1.0

1.1

—

Dermatopolymyositis

3.81

4.10

1.0

1.1

—

Respiratory tuberculosis

148

2.18

4.09

1.3

1.1

—

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

148

2.18

4.09

1.3

1.1

—

u/ml

—

Drug-induced systemic lupus erythematosus

6.63

4.02

1.0

1.1

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

2.70

4.00

1.1

1.3

—

Cystic kidney disease

2.62

3.98

1.0

1.1

—

Certain zoonotic bacterial diseases

3.17

3.95

1.1

—

Unspecified misadventure during surgical and medical care

144

2.17

3.93

1.1

—

Vitamin deficiency

112

2.34

3.93

1.1

1.2

—

Vitamin deficiency, wide

112

2.34

3.93

1.1

1.2

—

Personal history of other diseases and conditions

204

1.96

3.91

1.1

1.4

—

Synovial cyst of popliteal space [Baker]

172

2.05

3.85

1.2

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

152

2.12

3.84

1.3

1.1

—

Chronic lymphocytic leukaemia

2.63

3.82

1.1

1.2

—

Myeloproliferative diseases

228

1.90

3.82

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.55

3.81

1.5

1.1

—

u/ml

—

Allergic bronchopulmonary aspergillosis (ABPA)

12.48

3.80

1.3

1.0

—

u/ml

—

Artificial opening status

121

2.25

3.74

1.0

1.2

—

u/ml

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

188

1.98

3.72

1.2

1.1

—

Amenorrhoea

109

2.30

3.68

1.2

1.5

—

Other mycoses, not elsewhere classified/unspecified

8.24

3.62

1.0

—

Dental caries 2 and operation codes, only avohilmo

213

1725

0.76

3.59

1.3

—

54.07

u/ml

—

Hyphaema and other vascular disorders of iris and ciliary body

2.98

3.59

1.1

—

Other and unspecified mononeuropathies, also in other diseases

2.67

3.57

1.0

1.1

—

Vascular diseases of the intestine

2.41

3.56

1.2

—

u/ml

—

Hypoparathyroidism

2.47

3.56

1.0

—

Haemolytic-uraemic syndrome

10.59

3.55

1.0

—

Respiratory tuberculosis, confirmed

3.08

3.54

1.4

1.1

—

Benign neoplasm: Adrenal gland

192

1.94

3.53

1.1

—

Personal history of certain other diseases

3.89

3.53

1.3

1.1

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

6.28

3.52

1.0

—

Malignant neoplasm of thyroid gland

158

2.04

3.50

1.2

1.1

—

Tuberculosis, IBD comorbidity

200

1.91

3.48

1.3

1.1

—

u/ml

—

Personal history of malignant neoplasm

2.55

3.47

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

106

2.28

3.46

1.1

1.2

—

Erythema multiforme

2.79

3.43

1.4

1.0

—

Open wound of head

237

1826

1.28

3.39

1.2

1.3

—

75.40

u/ml

—

Psoriasis (vulgaris), strict definition

2.46

3.39

1.4

1.1

—

Moderate visual impairment, binocular

2.60

3.39

1.1

—

Complications peculiar to reattachment and amputation

5.87

3.37

1.1

1.0

—

Hypertension, Pulmonary Arterial

5.83

3.36

1.1

1.0

—

Malignant neoplasm

410

2010

1.21

3.33

1.1

1.3

—

38.80

u/ml

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.95

3.31

1.4

1.1

—

Nonischemic cardiomyopathy

148

2.04

3.31

1.1

—

Conduct disorder

2.95

3.31

1.0

1.4

—

Osteomyelitis of vertebra

8.96

3.30

1.2

1.1

—

Oesophageal varices

102

2.28

3.30

1.3

1.2

—

Scabies

115

2.19

3.29

1.2

1.1

—

u/ml

—

Optic neuritis

2.31

3.27

1.2

—

Non-Hodgkin lymphoma, all

103

2.25

3.23

1.1

1.2

—

Idiopathic thrombocytopenic purpura

2.46

3.22

1.4

1.1

—

Pleural plaque

279

1.73

3.22

1.3

1.1

—

u/ml

—

Pyoderma gangrenosum

5.47

3.21

1.0

1.1

—

Other and unspecified iridocyclitis

2.29

3.20

1.2

1.1

—

Benign neoplasm: Descending colon

178

1.92

3.19

1.1

—

Tuberculosis, wide

207

1.85

3.16

1.3

1.1

—

u/ml

—

Bursitis of shoulder

2.75

3.16

1.1

—

Alcoholic gastritis

3.00

3.15

1.0

1.1

—

Allergic urticaria

186

1.89

3.14

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

158

1.97

3.14

1.1

—

Hypoplasia of dental enamel, including avohilmo

4.61

3.14

2.0

1.8

—

Other abnormal findings in urine

3.12

3.10

1.4

1.1

—

Ascites

180

1.90

3.09

1.3

1.1

—

Other specified and unspecified retinal disorders

2.35

3.09

1.2

—

u/ml

—

Anosmia

4.48

3.08

1.4

1.1

—

Other disorders of amino-acid metabolism

7.72

3.08

1.2

1.1

—

Postmenopausal atrophic vaginitis

442

0.58

3.07

1.1

1.2

—

u/ml

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

3.50

3.06

1.4

1.1

—

Haemophagocytic lymphohistiocytosis

10.98

3.05

1.0

—

Cytomegaloviral pneumonitis

10.76

3.03

1.2

—

Calcinosis cutis

10.75

3.03

1.8

1.2

—

Dental pulpitis 2

348

1462

1.22

3.02

1.2

1.3

—

56.20

u/ml

—

Car occupant injured in noncollision transport accident

2.32

3.01

1.2

1.1

—

Lichenoid drug reaction

10.45

3.01

1.0

1.2

—

Benign neoplasm: Adrenal gland

204

1.83

2.99

1.1

—

Myeloproliferative diseases (CML excluded)

204

1.82

2.99

1.1

—

Background retinopathy and retinal vascular changes

2.66

2.98

1.3

1.1

—

Other general symptoms and signs

2.42

2.98

1.1

—

L01XE Protein kinase inhibitors

162

1.93

2.95

1.0

1.1

—

Acute alcohol intoxication ICD-9

2.29

2.94

1.1

1.2

—

Malnutrition

2.86

2.93

1.2

—

u/ml

—

Behavioural disorders

2.85

2.92

1.0

1.2

—

Benign neoplasm: Descending colon

184

1.86

2.92

1.1

—

Artificial joint re-operation

184

1.86

2.92

1.3

1.1

—

Thyroiditis

163

1.91

2.90

1.1

—

Pedestrian injured in other and unspecified transport accidents

4.15

2.89

1.2

1.0

—

u/ml

—

Disorders of pituitary gland, other and/or unspecified

6.82

2.88

1.2

1.1

—

Oligomenorrhoea

2.60

2.87

1.2

1.7

—

Other localized connective tissue disorders

2.96

2.87

1.3

1.2

—

Dermatographic urticaria

136

2.00

2.85

1.1

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.10

2.82

1.0

1.3

—

Other diseases of blood and blood-forming organs

179

1.85

2.82

1.2

1.1

—

u/ml

—

Guillain-Barre syndrome

3.10

2.82

1.1

—

Other and unspecified injuries of shoulder and upper arm

2.42

2.81

1.1

1.2

—

u/ml

—

L01XX Other antineoplastic agents

144

1.96

2.80

1.1

—

Lung transplant status

4.02

2.80

1.2

1.1

—

u/ml

—

Lung transplantation

4.02

2.80

1.2

1.1

—

u/ml

—

Motor neuron disease

3.26

2.78

1.1

—

Exposure to other specified factors

317

2461

1.21

2.78

1.1

1.3

—

53.44

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

117

2.07

2.78

1.1

—

Other and unspecified vaccines and biological substances

5.12

2.75

1.3

1.1

—

Rare circulating lymphoid malignancy

2.22

2.74

1.1

1.3

—

Degenerative macular diseases

324

1.61

2.74

1.3

1.1

—

u/ml

—

Intestinal malabsorption

111

2.09

2.73

1.1

—

Other diseases of biliary tract

218

1.75

2.72

1.1

—

Other disorders of carbohydrate metabolism

6.17

2.72

1.2

1.0

—

Dermatopolymyositis, unspecified

6.16

2.72

1.0

1.1

—

Unspecified protein-energy malnutrition

6.16

2.72

1.2

1.1

—

Myositis

2.45

2.72

1.2

1.4

—

Other acute viral hepatitis

3.80

2.68

1.0

—

Lesion of radial nerve

2.29

2.68

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

2.29

2.67

1.2

1.1

—

Postzoster neuralgia

3.17

2.66

1.4

1.0

—

ILD medications: nintedanib

4.80

2.62

1.1

—

Drug-induced polyneuropathy

4.75

2.61

1.0

1.1

—

Opening and dilatation of root channel of tooth

148

1.90

2.60

1.0

1.1

—

Aspergillosis

3.69

2.60

1.2

1.1

—

u/ml

—

ILD medications: pirfenidone

3.67

2.59

1.0

—

u/ml

—

Other nonthrombocytopenic purpura

4.08

2.58

1.0

1.1

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

7.44

2.58

1.0

1.1

—

Disorders of other and unspecified cranial nerves

5.59

2.56

1.0

1.1

—

Other abnormal immunological findings in serum

2.76

2.55

1.2

1.0

—

Benign neoplasm: Rectosigmoid junction

101

2.10

2.53

1.1

—

Other disorders of nervous system

179

1.80

2.51

1.1

—

Anorexia

3.50

2.49

3.3

1.1

—

Type 1 diabetes, definitions combined

224

1.70

2.47

1.0

1.4

—

Trigeminal neuralgia

123

1.96

2.45

1.0

1.1

—

Cyst of kidney

188

1.77

2.45

1.1

—

Vasomotor rhinitis (mode)

188

1.76

2.45

1.0

1.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

159

1.83

2.43

1.0

1.2

—

Benign neoplasm: Small intestine

103

2.05

2.42

1.0

1.2

—

Dental pulpitis 2, only avohilmo

353

1521

1.19

2.42

1.2

1.3

—

56.20

u/ml

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

351

1.54

2.41

1.1

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

117

1.98

2.41

1.9

1.2

—

Papillary adenocarcinoma of thyroid gland

124

1.95

2.40

1.3

1.1

—

Crohn disease (strict definition, all UC cases excluded)

117

1.98

2.40

1.0

1.1

—

Type 1 diabetes, strict (exclude DM2)

226

1.68

2.40

1.0

1.4

—

Drug-induced gout

6.41

2.39

1.0

—

Use of donepezil

545

0.60

2.37

1.1

—

Panniculitis, unspecified

3.69

2.37

1.0

1.1

—

Benign neoplasm: Rectum/anal canal icd-9

4.18

2.37

1.3

1.1

—

Disorders of optic nerve, not elsewhere classified

2.53

2.37

1.1

—

Lupus erythematosus

2.52

2.36

1.0

—

Other disorders of pigmentation

104

2.03

2.36

1.0

1.2

—

Psoriatic arthropathies

251

1.64

2.36

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

183

1.76

2.36

1.3

1.1

—

Malignant neoplasm of bladder

198

1.73

2.35

1.0

1.1

—

Benign neoplasm of eye and adnexa

267

1.62

2.34

1.6

1.1

—

Other salmonella infections

2.10

2.33

1.1

1.2

—

Respiratory tuberculosis, clinically confirmed

3.25

2.31

1.2

1.0

—

u/ml

—

Gluteal tendinitis

2.19

2.31

1.1

—

Vitamin D deficiency

2.89

2.31

1.2

—

Amblyopia ex anopsia

105

2.01

2.31

1.0

1.2

—

u/ml

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.78

2.30

1.2

1.1

—

Acquired pure red cell aplasia [erythroblastopenia]

4.75

2.29

1.0

1.1

—

Lack of expected normal physiological development

4.08

2.29

2.4

1.5

—

Abnormal reflex

4.73

2.29

1.0

1.1

—

Crystal arthropathies, rheuma endpoint

2.71

2.28

1.0

—

Other and unspecified nonscarring hair loss

4.70

2.28

1.7

1.2

—

Other and unspecified disorders of pigmentation

4.70

2.28

1.0

1.1

—

Other and unspecified injuries of forearm

4.69

2.28

1.8

1.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.53

2.28

1.1

1.2

—

Molar incisor enamel hypoplasia

2.38

2.27

1.8

1.3

—

Sacroiliitis, not elsewhere classified

2.08

2.27

1.3

1.2

—

Benign neoplasm: Small intestine

106

2.00

2.26

1.0

1.2

—

Benign neoplasm: Rectosigmoid junction

106

2.00

2.26

1.1

1.2

—

Ankylosing spondylitis

231

1.65

2.26

1.2

—

Benign neoplasm: Rectum/anal canal icd-9

3.94

2.26

1.3

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

420

1.46

2.25

1.1

1.2

—

Squamous cell neoplasms and carcinomas of the skin

358

1.51

2.24

1.1

—

Livedoid vasculitis

5.73

2.23

1.0

1.1

—

Other primary thrombocytopenia

5.71

2.23

1.4

1.1

—

Disorders of adrenal gland, other and/or unspecified

5.68

2.23

1.4

1.1

—

Early lumbar disc prolapse, operated

209

1.68

2.22

1.0

1.3

—

Benign neoplasm: Duodenum

2.36

2.22

1.1

—

Nosocomial condition (hospital)

5.66

2.22

1.0

—

Paralytic ileus

2.06

2.22

1.0

1.1

—

Spondylopathies in diseases classified elsewhere

2.82

2.21

2.2

1.2

—

Mature T/NK-cell lymphomas, hilmo

2.82

2.21

1.4

1.1

—

Motor neuron disease (with DMD)

2.80

2.21

1.1

—

Melanocytic naevi of upper limb, including shoulder

2.43

2.20

1.1

1.4

—

Benign neoplasm: Bronchus and lung

3.37

2.19

1.0

1.1

—

Other peripheral vascular diseases

195

1.70

2.19

1.1

—

Other and unspecified epidermal thickening

2.26

2.18

1.3

1.2

—

u/ml

—

Oral leukoplakia and related diseases

136

1.85

2.18

2.0

1.1

—

Subacute thyroiditis

2.25

2.18

1.1

—

Dementia in Alzheimer disease

431

0.59

2.18

1.1

—

u/ml

—

Disorders of parathyroid gland, other and/or unspecified

4.37

2.16

1.0

1.1

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

4.36

2.16

1.0

—

Neovascular glaucoma

115

1.93

2.16

1.4

1.2

—

Molar incisor enamel hypoplasia, with caries

3.74

2.15

1.6

1.8

—

Benign neoplasm of urinary organs

108

1.96

2.15

1.0

1.1

—

Hodgkin lymphoma

2.18

2.15

1.8

1.3

—

Alzheimer disease

715

0.70

2.15

1.1

—

u/ml

—

Oesophagitis

144

1.82

2.15

1.2

1.1

—

u/ml

—

Hypoplasia of dental enamel , including avohilmo

2.39

2.14

1.8

1.4

—

Congenital malformations of eye, ear, face and neck

144

1.81

2.14

1.0

1.2

—

u/ml

—

Benign neoplasm of eye and adnexa

274

1.58

2.14

1.6

1.2

—

Open wound of abdomen, lower back and pelvis

2.11

2.13

1.2

1.1

—

Disorders of synovium and tendon in diseases classified elsewhere

2.39

2.13

1.5

1.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.48

2.11

1.4

1.1

—

Complications following infusion, transfusion and therapeutic injection

2.59

2.11

1.2

1.1

—

Other and unspecified haemorrhagic conditions

2.59

2.10

1.3

1.0

—

u/ml

—

Other crystal arthropathies

2.59

2.10

1.0

1.1

—

3.24

2.10

1.0

—

Cholecystectomy

292

2186

1.18

2.09

1.1

1.3

—

38.80

u/ml

—

Golimumab

2.15

2.09

1.0

1.2

—

Mitochondrial myopathy

5.14

2.09

1.0

1.1

—

Other infiltrative disorders of skin and subcutaneous tissue

5.11

2.08

1.4

1.1

—

Cardiomyopathy in other diseases

5.11

2.08

1.2

1.0

—

Other autoimmune haemolytic anaemias

2.95

2.08

1.0

1.1

—

Other/unspecified crystal arthropathies

5.09

2.08

1.0

1.1

—

Anankastic personality disorder

2.09

2.07

1.2

1.1

—

Other nonscarring hair loss

3.55

2.06

1.6

1.1

—

Glaucoma secondary to other eye disorders

117

1.89

2.06

1.4

1.2

—

Family history of other conditions

3.54

2.06

1.0

1.4

—

Benign neoplasm: Tongue

2.19

2.05

1.1

—

u/ml

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

4.07

2.05

4.0

1.1

—

Enteropathic arthropathies

2.42

2.03

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

3.11

2.02

1.0

1.6

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

2.66

2.02

1.1

—

Benign neoplasm: Duodenum

2.24

2.01

1.1

1.2

—

Xerosis cutis

2.84

2.01

1.8

1.1

—

Benign neoplasm: Tongue

2.16

1.99

1.1

1.2

—

u/ml

—

Melanocytic naevi of upper limb, including shoulder

2.30

1.98

1.1

1.2

—

Carrier of infectious disease

2.30

1.98

1.1

—

Unspecified threat to breathing

3.38

1.97

1.0

1.1

—

Carcinoma in situ of skin

217

1.62

1.97

1.2

1.1

—

u/ml

—

Nonspecific lymphadenitis

141

1.78

1.97

1.1

1.3

—

Type 1 diabetes, strict definition, subgroup 1

163

1.72

1.96

1.0

1.4

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

171

1.70

1.96

1.1

—

u/ml

—

Disorders of orbit

105

1.92

1.96

1.3

1.1

—

Listeriosis

4.66

1.95

1.0

—

u/ml

—

Herpesviral keratitis and keratoconjunctivitis

1.99

1.95

1.2

1.1

—

u/ml

—

Female infertility, associated with anovulation

105

1.91

1.95

1.1

1.5

—

Systemic sclerosis,strict definition

3.80

1.94

1.0

1.1

—

Personal history of allergy to drugs, medicaments and biological substances

3.79

1.94

1.0

—

Cauda equina syndrome

2.76

1.94

1.1

—

Thyroiditis, unspecified

2.75

1.94

1.1

—

Carcinoma in situ of skin of other and unspecified parts of face

203

1.63

1.92

1.1

—

u/ml

—

Benign neoplasm of urinary organs

113

1.87

1.91

1.0

1.2

—

Viral meningitis

2.06

1.91

1.0

1.1

—

Other disorders of optic [2nd] nerve and visual pathways

165

1.71

1.91

1.1

1.2

—

Alzheimer disease, including avohilmo

827

0.75

1.90

1.1

—

u/ml

—

Vascular dementia

189

1.64

1.90

1.1

—

u/ml

—

Type 1 diabetes, strict definition

180

1.67

1.90

1.0

1.4

—

Encephalopathy

3.23

1.89

1.6

1.1

—

Alzheimer’s disease, wide definition

606

0.69

1.88

1.1

—

u/ml

—

Other and unspecified mononeuropathies of lower limb

2.17

1.88

1.2

1.0

—

Heterophoria

189

1.65

1.87

1.8

1.4

—

u/ml

—

Benign neoplasm: Skin of lip

2.89

1.87

1.0

—

Other and unspecified mononeuropathies of upper limb

2.10

1.86

1.2

1.1

—

Somnolence, stupor and coma

107

1.88

1.86

1.1

1.2

—

Other arterial embolism and thrombosis

2.04

1.86

1.3

1.2

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.99

1.85

1.1

1.2

—

u/ml

—

Hypermobility syndrome

2.03

1.85

1.1

—

u/ml

—

Thiamine deficiency

3.61

1.85

1.2

1.1

—

Central retinal artery occlusion

2.22

1.85

1.1

1.3

—

Unspecified event, undetermined intent

2.22

1.84

1.0

1.2

—

Felty syndrome

4.24

1.83

1.2

1.1

—

Other specified/unspecified spondylopathies

2.14

1.82

1.2

1.3

—

Follow-up examination after treatment for malignant neoplasms

278

1.52

1.81

1.5

1.1

—

Exclusion endpoint for clefts

2.28

1.81

1.1

1.4

—

IBD (strict) with PSC

3.08

1.80

1.7

1.1

—

Hodgkin lymphoma, hilmo

2.02

1.80

1.8

1.2

—

Mixed conductive and sensorineural hearing loss

352

1.45

1.80

1.5

1.1

—

u/ml

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.79

1.80

1.1

—

Benign neoplasm: Skin of lip

2.79

1.80

1.0

1.1

—

Intestinal adhesions without obstruction

215

1.59

1.79

1.1

—

Benign neoplasm: other/unspecified salivary gland

2.11

1.76

1.1

1.2

—

Carcinoma in situ of skin

224

1.57

1.76

1.2

1.1

—

u/ml

—

Peptic ulcer

3.37

1.75

1.0

1.1

—

Polycythaemia vera

1.99

1.75

1.1

1.2

—

Donors of organs and tissues

2.53

1.74

1.0

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.03

1.74

1.5

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

209

1.59

1.73

1.1

—

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

110

1.83

1.73

1.4

1.2

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

110

1.83

1.73

1.4

1.2

—

Evidence of alcohol involvement determined by level of intoxication

2.95

1.73

1.3

1.0

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.94

1.73

1.1

—

Renal agenesis and other reduction defects of kidney

3.93

1.72

1.4

1.1

—

Iron deficiency

2.68

1.72

1.0

1.3

—

Sequelae of intentional self-harm, assault and events of undetermined intent

3.90

1.72

1.0

—

Protein-energy malnutrition of moderate and mild degree

3.89

1.72

1.2

1.1

—

u/ml

—

Alzheimer’s disease (Late onset)

548

0.69

1.72

1.2

1.1

—

u/ml

—

Other abnormal findings of blood chemistry

103

1.85

1.72

1.0

1.2

—

Achilles tendinitis

282

1.49

1.71

1.2

1.1

—

6-mercaptopurine

2.30

1.70

1.1

—

Benign neoplasm: other/unspecified salivary gland

2.07

1.70

1.1

—

Umbilical hernia

112

883

1.27

1.70

1.2

—

u/ml

—

Renal cell carcinoma of kidney

1.92

1.70

1.1

1.2

—

u/ml

—

Right hemicolectomy

156

1.67

1.69

1.0

1.1

—

u/ml

—

Unspecified urinary incontinence

203

1.58

1.68

1.1

—

u/ml

—

Use of rivastigmine

356

0.59

1.68

1.1

—

Other and unspecified abdominal hernia

104

1.84

1.67

2.3

1.0

—

Other specified/unspecified soft tissue disorders

104

1.83

1.67

1.1

1.2

—

Other and unspecified injuries of neck

3.20

1.67

1.0

1.1

—

u/ml

—

Tarsal tunnel syndrome

3.19

1.66

1.0

1.1

—

Combined immunodeficiencies

3.19

1.66

1.0

1.1

—

Benign neoplasm: Choroid

157

1.66

1.2

1.1

—

Sixth [abducent] nerve palsy

1.90

1.65

1.1

1.2

—

Hyperaldosteronism

2.04

1.65

1.0

1.1

—

Campylobacter enteritis

2.04

1.65

1.0

1.1

—

Abnormal blood-pressure reading, without diagnosis

1.94

1.64

1.2

1.1

—

Malignant neoplasm of renal pelvis

3.64

1.62

4.8

1.1

—

Birth asphyxia

3.63

1.62

1.0

1.7

—

Benign neoplasm: Choroid

158

1.65

1.62

1.2

1.1

—

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

3.61

1.62

1.0

—

Myotonic disorders

3.61

1.62

1.6

1.1

—

Any event in cancer register

401

2101

1.13

1.61

1.1

1.3

—

32.42

u/ml

—

Volvulus

2.16

1.61

1.0

1.1

—

Open wound of thorax

2.35

1.61

1.6

1.1

—

Benign neoplasm: Bronchus and lung

2.53

1.60

1.0

1.1

—

Fall involving bed

1.96

1.59

1.9

1.2

—

Filling of root of tooth

2.01

1.59

1.0

1.1

—

conjunctival haemorrhage

206

1.56

1.59

1.7

1.1

—

Polymyositis

3.04

1.59

1.0

1.1

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

3.04

1.59

1.0

1.1

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

2.72

1.59

1.0

1.5

—

Other and unspecified aplastic anaemias

2.72

1.58

1.0

—

Other secondary gonarthrosis

144

1.67

1.57

1.1

—

Other acute skin changes due to ultraviolet radiation

1.89

1.55

1.0

1.2

—

u/ml

—

Other menopausal disorders

450

0.73

1.55

1.1

1.2

—

Other benign neoplasms of connective and other soft tissue

248

1.50

1.54

1.2

1.1

—

Ulcerative enterocolitis

1.93

1.54

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.93

1.54

1.0

1.2

—

Congenital malformations of breast

2.44

1.54

1.0

1.3

—

Faecal incontinence

192

1.57

1.54

1.2

1.1

—

Acquired clawhand, clubhand, clawfoot and clubfoot

3.39

1.53

1.0

1.1

—

Anuria and oliguria

3.38

1.53

1.4

1.1

—

Migraine, unspecified, drug-induced

3.38

1.53

1.2

1.1

—

Hyperkinetic disorders (excl. ADHD)

0.00

1.53

0.0

1.4

—

Personal history of medical treatment

3.37

1.53

1.2

1.1

—

Radial styloid tenosynovitis [de Quervain]

115

1.75

1.52

1.0

1.4

—

Seminoma of testis

2.62

1.52

1.0

1.1

—

Contact with sharp glass

1.84

1.51

1.3

1.2

—

u/ml

—

Traction detachment of retina

2.89

1.51

1.0

—

Benign neoplasm: Nasopharynx

2.89

1.51

1.2

1.0

—

Migraine with aura, drug-induced

2.88

1.51

1.2

1.1

—

Contusion of ankle

1.87

1.50

1.1

1.2

—

Endometriosis of pelvic peritoneum

361

1.40

1.50

1.1

1.2

—

Use of other anti-dementia drugs

671

0.74

1.50

1.1

—

u/ml

—

Use of memantine

671

0.74

1.50

1.1

—

u/ml

—

Disorder of external ear, unspecified

1.91

1.49

1.1

—

Other puerperal infections

126

0.40

1.49

1.0

1.3

—

Other/unspecified enthesopathies of lower limb, excluding foot

162

1.61

1.49

1.3

1.1

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

1.96

1.49

1.0

1.2

—

Follow-up care involving plastic surgery

1.95

1.49

1.0

—

Dissociative [conversion] disorders

1.95

1.49

1.0

1.2

—

Clear cell adenocarcinoma of kidney

139

1.66

1.48

1.9

1.1

—

Congenital malformations of uterus and cervix

2.45

1.48

1.2

1.1

—

Degenerative diseases of the nervous system

819

0.78

1.48

1.1

—

u/ml

—

Allergic contact dermatitis

317

1.42

1.47

1.5

1.1

—

Assault by sharp object

2.24

1.47

1.4

1.1

—

Use of galantamine

169

0.47

1.46

1.0

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

2.39

1.46

1.0

1.1

—

Mantle cell lymphoma

2.54

1.46

1.0

1.1

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.38

1.46

1.3

1.9

—

Acute hepatitis B

3.19

1.45

1.0

1.1

—

Fibrosis of liver

3.17

1.44

1.0

1.1

—

Bus occupant injured in other and unspecified transport accidents

3.17

1.44

1.0

1.1

—

Benign neoplasm: Nasopharynx

2.76

1.44

1.2

1.1

—

Unknown and unspecified causes of morbidity

125

1.68

1.43

1.1

—

Endometriosis of rectovaginal septum and vagina

172

1.57

1.42

1.3

1.4

—

Melanocytic naevi, other sites/unspecified

188

1.55

1.42

1.1

1.3

—

u/ml

—

Fracture of forearm

208

1668

1.17

1.42

1.3

—

43.33

u/ml

—

Benign neoplasm: Other and unspecified parts of small intestine

2.27

1.40

1.0

1.1

—

Other specified congenital malformation syndromes affecting multiple systems

2.19

1.40

1.1

1.4

—

Melanocytic naevi, other sites/unspecified

189

1.54

1.40

1.1

1.3

—

u/ml

—

Other injuries of upper limb, level unspecified

2.44

1.40

1.0

1.3

—

Other chondrocalcinosis

2.44

1.40

1.0

1.1

—

Osteonecrosis due to drugs

2.44

1.40

1.3

1.1

—

Occlusion and stenosis of arteries, not leading to stroke

2.43

1.39

1.0

—

Fistulae involving female genital tract

2.43

1.39

1.0

—

Complications of labour and delivery

149

997

0.83

1.39

1.3

—

27.30

u/ml

—

Type1 diabetes, definitions combined, early onset

157

1.59

1.38

1.0

1.5

—

Lesion of plantar nerve

142

1.63

1.38

1.1

—

Vascular dementia (subcortical)

2.01

1.38

1.0

1.3

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.64

1.37

1.0

1.5

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.64

1.37

1.0

—

Other and unspecified bullous disorders

2.64

1.37

1.2

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

1.81

1.37

1.4

1.0

—

Diseases caused by chlamydiae

2.63

1.37

4.7

1.1

—

Respiratory tuberculosis, not confirmed

104

1.74

1.37

1.2

—

u/ml

—

Foreign body in respiratory tract

127

1.66

1.36

1.0

1.1

—

Acute myringitis

2.98

1.36

1.0

1.1

—

Use of selegiline

124

0.40

1.36

1.0

1.2

—

Presence of other devices

652

1.27

1.36

1.2

—

Use of amantadine

0.00

1.35

0.0

1.1

—

Other specified/unspecified disorders of bone/cartilage

1.88

1.34

1.1

—

Acute posthaemorrhagic anaemia

1.88

1.34

1.2

—

Benign neoplasm: Skin of upper limb, including shoulder

2.16

1.34

3.7

1.1

—

Congenital malformations of genital organs

182

1.53

1.33

1.2

1.3

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.92

1.33

1.1

—

Degeneration of the brain due to alcohol

1.98

1.33

1.1

1.3

—

Paraplegia, diplegia of upper limbs

2.05

1.33

1.1

—

u/ml

—

Rheumatic valve diseases

2.05

1.33

1.1

1.0

—

Benign neoplasm: Skin of trunk

1.74

1.31

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.53

1.31

1.0

1.1

—

Fasciculation

2.52

1.31

1.0

1.1

—

Melanoma in situ of trunk

2.52

1.31

1.0

1.5

—

Other nutritional anaemias

2.52

1.30

1.0

1.1

—

Sequelae of tuberculosis

2.11

1.30

1.2

1.0

—

u/ml

—

Viral conjunctivitis

2.11

1.30

1.1

—

Benign neoplasm: Anus and anal canal

1.85

1.30

1.3

1.2

—

Benign neoplasm: Anus and anal canal

1.85

1.30

1.3

1.1

—

Inflammatory disease of uterus

292

1.41

1.30

1.1

1.2

—

u/ml

—

Abscess of external ear

2.37

1.29

1.0

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

137

1.61

1.29

1.1

1.4

—

u/ml

—

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

2.81

1.29

4.8

1.7

—

Lichen simplex chronicus and prurigo

169

1.54

1.28

1.2

1.1

—

u/ml

—

Retinoschisis and retinal cysts

1.95

1.28

1.1

—

Appendectomy

255

2156

1.14

1.28

1.4

1.3

—

49.07

u/ml

—

Embolic stroke with flimmer

1.95

1.28

1.1

1.2

—

Colitis, primary sclerosing

2.31

1.27

1.6

1.1

—

Morphin

2.30

1.27

1.0

1.1

—

u/ml

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.06

1.27

1.6

1.3

—

Other benign neoplasms of connective and other soft tissue

260

1.43

1.26

1.2

—

Ulcerative proctitis

138

1.60

1.26

1.2

1.1

—

Dental caries 2, only avohilmo

234

2109

0.87

1.26

1.3

—

53.44

u/ml

—

Pigmented purpuric dermatosis

2.42

1.25

1.0

1.1

—

Other diseases caused by chlamydiae

2.42

1.24

4.7

1.1

—

Benign neoplasm: Vagina

2.42

1.24

1.3

1.1

—

Hyperosmolality and hypernatraemia

2.42

1.24

1.0

1.5

—

u/ml

—

Family history of other specific disorders

2.42

1.24

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.87

1.24

1.0

1.1

—

Degeneration of nervous system due to alcohol

1.92

1.23

1.1

1.3

—

Left hemicolectomy

1.92

1.23

1.2

1.1

—

Papilloedema, unspecified

1.98

1.22

1.3

1.1

—

Diastasis of muscle

2.66

1.22

1.0

1.1

—

Ovarian cyst

123

588

1.21

1.22

1.1

1.2

—

Postpartum hemorraghe, parous women as controls

441

0.71

1.22

1.1

1.2

—

Use of levodopa decarboxylase inhibitor

409

0.68

1.22

1.0

1.1

—

Perforation of tympanic membrane

271

1.41

1.21

1.7

1.1

—

u/ml

—

Other noninflammatory disorders of vagina

164

1.53

1.20

1.1

1.3

—

Muscle strain

1.84

1.19

1.1

1.2

—

Benign neoplasm: Cerebral meninges

230

1.44

1.19

1.2

1.1

—

u/ml

—

Any dementia

107

914

0.82

1.19

1.1

—

u/ml

—

Essential (haemorrhagic) thrombocythaemia

1.75

1.19

1.1

1.2

—

Acquired absence of organs, not elsewhere classified

2.33

1.19

1.2

1.5

—

Carcinoma in situ of skin of ear and external auricular canal

2.32

1.19

1.0

1.5

—

Secondary polycythaemia

1.89

1.18

1.0

1.1

—

u/ml

—

Myeloid leukaemia

1.89

1.18

1.3

1.2

—

Benign neoplasm: Skin of trunk

102

1.67

1.16

1.2

1.1

—

Universal erythroderma, KELA reimbursement

2.07

1.15

1.0

1.1

—

Cholesteatoma of external ear

2.53

1.15

1.0

1.1

—

u/ml

—

Infliximab

2.53

1.15

1.2

1.1

—

Cushing syndrome

2.52

1.15

1.0

1.1

—

Dissection of aorta

1.73

1.15

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

126

1.59

1.14

1.1

1.2

—

Endovascular or surgical operations to intracerebral aneurysms

153

0.52

1.14

1.0

1.1

—

Pustulosis palmaris et plantaris

1.69

1.14

1.3

1.1

—

Disorders of iron metabolism

2.35

1.12

1.3

1.1

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.91

1.12

1.1

—

Malignant neoplasm of eye, brain and central nervous system

114

0.44

1.12

1.2

—

Other and unspecified disease of Bartholin gland

1.91

1.12

1.2

1.0

—

Abnormalities of forces of labour

221

0.59

1.12

1.0

1.1

—

Atopic dermatitis

190

1410

1.15

1.11

1.2

1.3

—

51.25

u/ml

—

Malignant neoplasm of other and unspecified parts of biliary tract

2.28

1.11

1.0

1.1

—

Arthropathy in ulcerative colitis

2.28

1.10

1.1

—

Carcinoma in situ of other and unspecified sites

1.68

1.10

2.2

1.2

—

u/ml

—

Vulvovaginal ulceration/inflammation in other diseases

1.67

1.10

1.1

1.5

—

Fracture of neck

160

1.51

1.09

1.1

—

u/ml

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.83

1.09

1.0

1.2

—

u/ml

—

Accidental poisoning by and exposure to alcohol

1.96

1.09

1.1

1.2

—

All dysplastic lesions of the vulva

1.73

1.09

1.2

1.4

—

Haemorrhagic disorder due to circulating anticoagulants

2.21

1.08

1.0

—

Benign neoplasm: Cerebral meninges

235

1.41

1.08

1.2

1.1

—

u/ml

—

Aphakia

2.20

1.08

1.4

—

Other diseases of spinal cord

1.77

1.07

1.0

1.1

—

HSIL lesion of the vulva

2.13

1.06

1.4

1.1

—

2.13

1.05

1.3

1.5

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.13

1.05

3.7

1.0

—

Lichen simplex chronicus

1.72

1.05

1.4

1.1

—

u/ml

—

Injury of intra-abdominal organs

1.80

1.05

1.0

1.1

—

Other symptoms and signs involving general sensations and perceptions

1.67

1.04

1.0

1.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.97

1.04

1.0

1.4

—

Hereditary deficiency of other clotting factors

2.29

1.03

1.4

1.1

—

Hyperhidrosis

1.96

1.03

1.0

1.1

—

Chronic myeloproliferative disease

2.08

1.03

1.1

—

Nystagmus and other irregular eye movements

2.07

1.03

2.3

1.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

130

1.54

1.02

1.1

1.2

—

Drug-induced hypoglycaemia without coma

1.93

1.02

1.0

1.1

—

Diseases of spleen

1.93

1.02

1.4

1.1

—

Benign neoplasm of meninges

255

1.38

1.02

1.2

1.1

—

u/ml

—

Entropion and trichiasis of eyelid

238

1.39

1.02

1.1

—

Retinal detachment with retinal break

377

1.30

1.01

1.1

—

u/ml

—

Carcinoma in situ of skin of upper limb, including shoulder

1.89

1.00

1.0

1.3

—

Symptoms and signs involving emotional state

1.77

1.00

1.0

1.2

—

Injuries involving multiple body regions

1.66

1.00

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

147

1.50

1.00

1.1

1.3

—

u/ml

—

Vascular dementia (mixed)

2.01

1.00

1.1

—

Recurrent dislocation and subluxation of joint

147

1.50

1.00

1.1

—

Benign neoplasm: Other/unspecified site

2.01

1.00

1.0

1.1

—

Benign neoplasm: Short bones of upper limb

2.01

1.00

1.1

—

Benign neoplasm: Kidney

1.72

0.99

1.0

1.2

—

Operations for atrial fibrillation

1.85

0.99

1.0

1.1

—

Normal-pressure hydrocephalus

132

0.53

0.99

1.0

1.1

—

Benign neoplasm: Skin of upper limb, including shoulder

1.85

0.99

3.7

1.1

—

Any dementia, excluding more controls

100

828

0.84

0.99

1.1

1.2

—

u/ml

—

Intentional self-harm by sharp object

1.84

0.98

1.0

1.2

—

Malignant neoplasm of parotid gland

2.20

0.98

1.0

1.1

—

Hypothyroidism due to medicaments and other exogenous substances

2.19

0.98

1.0

—

u/ml

—

Benign neoplasm: Bladder

2.19

0.98

1.0

1.1

—

Benign neoplasm: Bladder

2.19

0.98

1.0

—

Postpartum haemorrhage due to anatomy

158

0.57

0.98

1.3

—

Oesophageal obstruction

1.67

0.98

1.1

—

Benign neoplasm: Other/unspecified site

1.96

0.97

1.0

1.1

—

Erosion of teeth

1.96

0.97

1.1

1.6

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

100

1.61

0.97

1.8

1.2

—

Myeloid leukaemia

1.75

0.96

1.3

1.1

—

Secondary parkinsonism+Parkinsonism in other disease

1.75

0.96

1.0

1.1

—

Suppurative otitis media, unspecified

1.86

0.96

1.4

1.2

—

Other and unspecified injuries of thorax

1.77

0.95

1.0

1.1

—

Injury of unspecified body region

191

1.42

0.94

1.1

—

Other erythematous conditions

1.65

0.94

1.0

1.1

—

u/ml

—

Blood alcohol or alcohol intoxication level

1.78

0.94

1.3

1.1

—

Dementia in other diseases classified elsewhere

116

0.52

0.94

1.2

1.1

—

Parkinson's disease, including avohilmo

478

0.75

0.94

1.0

1.1

—

u/ml

—

Benign neoplasm of other and unspecified intrathoracic organs

2.24

0.94

1.0

—

Benign neoplasm of other and unspecified intrathoracic organs

2.24

0.94

1.0

—

Alzheimer’s disease (Late onset), excluding more controls

305

0.74

0.94

1.1

—

u/ml

—

Other disorders of central nervous system

2.24

0.94

2.2

1.1

—

UC patients in KELA-register (code 208), prior to 1994

117

1.54

0.93

1.3

1.2

—

Other bullous disorders

1.72

0.93

1.2

—

Prurigo nodularis

1.83

0.92

1.0

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.16

0.92

1.2

1.1

—

Disease of hard tissues of teeth, NOS

2.16

0.92

1.2

1.1

—

Other and unspecified erythematous conditions

1.67

0.91

1.0

1.1

—

u/ml

—

Cerebral cysts

126

1.51

0.91

1.3

1.2

—

Carcinoma in situ, bladder

1.64

0.91

2.4

1.2

—

u/ml

—

Carcinoma in situ of other and unspecified sites

102

1.58

0.90

2.3

1.2

—

u/ml

—

Chronic suppurative otitis media

176

1.42

0.90

1.4

1.2

—

Post-traumatic wound infection, not elsewhere classified

1.75

0.90

1.0

1.1

—

Deep endometriosis

193

1.40

0.90

1.3

1.1

—

Vitiligo

2.08

0.89

1.0

1.1

—

Benign neoplasm: Vagina

2.08

0.89

1.3

1.0

—

Toxic effect of other and unspecified substances

2.08

0.89

1.0

1.1

—

Postprocedural disorders of digestive system, not elsewhere classified

1.70

0.89

1.1

—

Non-allergic asthma

245

1.35

0.88

1.7

1.2

—

u/ml

—

Dystonia

127

1.50

0.88

1.2

1.1

—

u/ml

—

Allergic contact dermatitis due to drugs in contact with skin

1.80

0.88

1.0

1.1

—

Examination and encounter for administrative purposes

111

1.54

0.87

1.1

—

Status epilepticus

1.62

0.87

1.4

1.2

—

Inflammatory disorders of breast

111

1.54

0.87

1.1

—

Hypertrophy of (infrapatellar) fat pad

2.02

0.87

1.0

1.1

—

Intracranial and intraspinal abscess and granuloma

2.02

0.87

1.0

1.1

—

u/ml

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

2.01

0.87

1.3

1.0

—

LSIL lesion of the vagina

2.01

0.87

1.3

1.1

—

Other and unspecified diseases of blood and blood-forming organs

1.73

0.86

1.4

1.2

—

Other interventions on the root canals of the tooth

1.83

0.86

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

120

1.51

0.85

1.1

—

Ptosis of eyelid

308

1.30

0.85

1.1

—

Seborrhoeic dermatitis

273

1.32

0.85

1.1

—

u/ml

—

Localized scleroderma [morphea]

1.95

0.84

1.0

1.3

—

Medial epicondylitis

1.63

0.84

1.5

1.1

—

Dislocation of lens

1.95

0.84

1.0

1.4

—

Heart failure and hypertrophic cardiomyopathy

1.79

0.84

1.0

1.1

—

Other specific arthropathies, wide

1.79

0.84

1.0

1.1

—

Other specified/unspecified bacterial intestinal infections

162

1.42

0.84

1.1

1.2

—

Benign neoplasm: Stomach

274

1.32

0.83

1.1

—

Alzheimer’s disease, wide definition, excluding more controls

335

0.77

0.83

1.1

—

u/ml

—

Malignant neoplasm of stomach

129

1.48

0.83

1.0

1.1

—

Other lack of coordination

1.75

0.82

1.0

1.1

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

1.75

0.82

1.0

1.3

—

All dysplastic lesions of the vagina

1.75

0.82

1.3

1.1

—

Traumatic ischaemia of muscle

1.89

0.82

1.2

1.1

—

Cerebral atherosclerosis

1.88

0.81

1.0

—

u/ml

—

Meralgia paraesthetica

1.65

0.81

3.8

1.1

—

Polyhydramnios

1.65

0.81

1.3

1.6

—

Rheumatic fever incl heart disease

1.61

0.81

1.1

1.2

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

189

1.38

0.81

1.5

1.1

—

Intussusception

1.71

0.81

1.1

—

Benign neoplasm: Pancreas

1.73

0.80

1.0

1.3

—

Exfoliative dermatitis

1.83

0.79

1.0

1.1

—

Melanoma in situ of trunk

1.83

0.79

1.0

1.1

—

Toxic liver disease

1.83

0.79

1.2

1.1

—

Embolic stroke

114

1.49

0.79

1.1

1.2

—

Pyoderma

1.67

0.79

1.1

1.3

—

Correction of physiology of bite - demanding therapy visit

148

1.42

0.77

1.6

1.1

—

Other disorders of breast and lactation associated with childbirth

0.00

0.77

0.0

1.1

—

Guttate psoriasis

1.77

0.76

1.0

1.1

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

1.77

0.76

1.0

1.4

—

Memory loss

245

0.69

0.76

1.1

—

Parkinson's disease

461

0.78

0.76

1.0

1.1

—

u/ml

—

Cervicocranial syndrome

261

1.30

0.76

1.2

—

u/ml

—

Secondary parkinsonism

1.65

0.75

1.0

1.1

—

Agoraphobia

1.65

0.75

1.0

1.2

—

Contact with other hot fluids

1.61

0.75

1.2

1.1

—

Benign neoplasm: Kidney

1.57

0.75

1.0

1.2

—

Other congenital malformations, not elsewhere classified

2.10

0.75

1.0

1.6

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

2.10

0.75

1.0

—

Colitis, primary sclerosing, strict definition

2.10

0.75

1.4

1.1

—

Ovarian dysfunction

116

1.47

0.74

1.1

1.4

—

u/ml

—

Hypotension due to drugs

1.85

0.74

1.0

1.1

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.85

0.73

1.1

—

Malignant neoplasm of rectosigmoid junction

1.85

0.73

1.0

1.1

—

Benign neoplasm: Short bones of upper limb

1.85

0.73

1.1

—

Parkinson's disease, strict definition

425

0.78

0.73

1.0

1.1

—

Disorders in reading

1.85

0.73

1.1

1.3

—

Chronic suppurative otitis media, including avohilmo

210

1.34

0.73

1.3

1.1

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

2.01

0.73

1.0

1.1

—

Abnormal spermatozoa

413

0.77

0.73

1.1

—

u/ml

—

Unspecified human immunodeficiency virus [HIV] disease

2.01

0.73

1.0

1.1

—

Habit and impulse disorders

1.80

0.72

1.0

1.2

—

Hepatocellular carcinoma

1.61

0.72

1.2

1.1

—

Benign neoplasm of other and unspecified female genital organs

1.53

0.72

1.2

1.0

—

Contact with sharp object, undetermined intent

1.67

0.72

1.0

1.3

—

Abrasion of teeth

603

0.84

0.72

1.5

1.1

—

Carcinoma in situ of other and unspecified digestive organs

1.63

0.72

1.1

1.2

—

Dislocation, sprain and strain of joints and ligaments of head

1.55

0.72

1.1

—

u/ml

—

Corneal scars and opacities

1.62

0.72

1.4

1.1

—

Burn and corrosion of ankle and foot

1.76

0.71

1.4

1.1

—

Other and specified injuries of hip and thigh

1.59

0.71

1.1

—

Benign neoplasm: Oesophagus

1.93

0.71

1.6

1.1

—

Spinal osteochondrosis

1.93

0.71

1.4

1.2

—

Generalized epilepsy

101

1.49

0.70

1.1

—

Portal vein thrombosis

1.72

0.70

1.0

1.1

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

1.71

0.70

1.0

1.3

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.51

0.69

1.2

1.5

—

Spirochaetal infections, other/unspecified

228

0.70

0.69

1.1

—

Disorders of brain, other and unspecified

1.86

0.68

1.4

1.1

—

Injury of nerves at lower leg level

1.86

0.68

1.0

1.1

—

Melanoma in situ of other and unspecified parts of face

1.86

0.68

1.2

1.4

—

Benign neoplasm of other and unspecified sites

1.56

0.68

1.2

1.1

—

Carcinoma in situ of breast, other/unspecified

1.86

0.68

1.0

1.1

—

Other lesions of median nerve

1.65

0.68

1.0

1.1

—

Pathological resorption of teeth

1.64

0.68

1.0

1.1

—

Autoimmune thyroiditis

1.86

0.68

1.0

1.1

—

Perioral dermatitis

1.67

0.68

1.3

1.2

—

Erythema intertrigo

1.53

0.68

1.0

1.1

—

Benign neoplasm: Skin of scalp and neck

1.53

0.68

1.0

1.3

—

Granulomatous disorders of skin and subcutaneous tissue

1.53

0.68

1.1

—

Malignant neoplasm of colon

437

1.21

0.68

1.1

—

u/ml

—

Polycystic ovarian syndrome, broad definition

179

1.34

0.66

1.1

1.3

—

u/ml

—

Colitis due to radiation

1.80

0.66

1.0

1.5

—

Melanoma in situ of other and unspecified parts of face

1.80

0.66

1.2

1.1

—

Palindromic rheumatism

1.80

0.66

1.0

1.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

285

1.27

0.66

1.1

—

u/ml

—

Benign neoplasm of other and unspecified sites

1.54

0.65

1.2

1.1

—

Astigmatism

145

1.38

0.65

1.0

1.2

—

u/ml

—

Myasthenia gravis

1.60

0.65

1.0

1.1

—

Other intracranial haemorrhages

1.58

0.65

1.1

1.2

—

Other disorders of bone density and structure

1.62

0.65

1.2

1.1

—

Amputation of thigh

1.58

0.65

1.3

1.2

—

Other diseases of gallbladder

103

1.46

0.65

1.5

1.0

—

u/ml

—

Contusion of other and unspecified parts of foot

1.48

0.64

1.0

1.2

—

Chronic hepatitis NAS

1.73

0.64

1.2

1.1

—

Other congenital malformations of ear

1.73

0.64

1.0

1.3

—

Bullous disorders

146

1.37

0.63

1.3

1.2

—

Pustular psoriasis

112

1.43

0.63

1.3

1.1

—

Other noninfective disorders of lymphatic vessels and lymph nodes

1.52

0.62

1.6

1.1

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

121

1.41

0.62

1.1

1.0

—

Torsion of testis

1.64

0.62

1.1

—

Other disorders of binocular movement

1.64

0.62

1.9

1.2

—

Retinal haemorrhage

1.59

0.62

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.67

0.61

1.4

—

Carcinoma in situ, bladder

1.46

0.61

2.4

1.2

—

u/ml

—

Granuloma annulare

1.67

0.61

1.2

1.0

—

Hirsutism in women

1.67

0.61

1.0

1.3

—

Hypertrophic cardiomyopathy

113

1.42

0.61

1.1

—

Respiratory distress of newborn

1.66

0.61

1.0

1.8

—

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.1

—

Severe visual impairment, monocular

0.00

0.60

0.0

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.1

—

Scoliosis

200

1.30

0.60

1.0

1.2

—

Additional codes for the location of defect, injury or illness

139

1.37

0.60

1.1

—

Open wound of neck

0.00

0.60

0.0

1.1

—

Other osteochondrodysplasias

0.00

0.60

0.0

1.4

—

Polyp of the female genital tract

505

1.14

0.60

1.1

1.2

—

Juvenile osteochondrosis

1.53

0.59

1.1

1.2

—

Atopic conjunctivitis

1.45

0.59

1.1

—

Wet age-related macular degeneration

482

1.18

0.59

1.1

—

Fourth [trochlear] nerve palsy

1.57

0.58

1.0

1.1

—

Burns and corrosions of multiple body regions

0.00

0.58

0.0

1.3

—

Benign neoplasm of male genital organs

1.51

0.58

2.5

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS